Fosun International’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Fosun International’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-90,963	Closed	-$1.62M	–	339
2018 Q3	$1.62M	Buy	+90,963	New	+$1.56M	0.08%	106

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Fosun International's ECYT Position: Q4 2018 in Review

Fosun International sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 90,963 shares — an estimated $1.62M sold.

Fosun International first reported a position in ECYT in Q3 2018 and held it in 1 quarter. The position peaked at $1.62M in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Fosun International reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Fosun International sold 90,963 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $1.62M.
Fosun International first reported a position in Endocyte, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
Fosun International's Endocyte, Inc. Common Stock position peaked at $1.62M in Q3 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Fosun International's 13F filing for Q4 2018, filed 31 Jan 2019.